Clal Insurance’s Elanco Animal Health ELAN Stock Holding History

Clal Insurance’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-134	Closed	-$2K	–	205
2024 Q4	$2K	Buy	+134	New	+$1.75K	﹤0.01%	171

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Clal Insurance's ELAN Position: Q1 2025 in Review

Clal Insurance sold out of Elanco Animal Health (ELAN) in Q1 2025, closing a stake of 134 shares — an estimated $2K sold.

Clal Insurance first reported a position in ELAN in Q4 2024 and held it in 1 quarter. The position peaked at $2K in Q4 2024. 364 funds tracked by Wall St. Rank hold ELAN as of Q1 2025.

Clal Insurance reported no remaining Elanco Animal Health position as of Q1 2025 after selling out during the quarter.
Clal Insurance sold 134 Elanco Animal Health shares in Q1 2025, an estimated $2K.
Clal Insurance first reported a position in Elanco Animal Health in Q4 2024 and held it in 1 quarter.
Clal Insurance's Elanco Animal Health position peaked at $2K in Q4 2024.
364 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2025.

Based on Clal Insurance's 13F filing for Q1 2025, filed 13 May 2025.